We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Tompkins Financial
TMP
$1.45B
| $306K | ﹤0.01% |
4,619
-600
| -11% | -$44.1K |
|
|
BLUE
1002
DELISTED
bluebird bio
BLUE
| $304K | ﹤0.01% |
4,782
-1,529
| -24% | -$175K |
|
1003
Alnylam Pharmaceuticals
ALNY
$30.4B
| $302K | ﹤0.01% |
1,507
-560
| -27% | -$118K |
|
1004
WillScot Mobile Mini Holdings
WSC
$4.07B
| $302K | ﹤0.01% |
6,439
| – | – |
|
|
CALY
1005
Callaway Golf Company
CALY
$2.99B
| $302K | ﹤0.01% |
+13,947
| New | +$316K |
|
1006
Freeport-McMoran
FCX
$94.5B
| $301K | ﹤0.01% |
7,354
-235
| -3% | -$9.78K |
|
1007
Saia
SAIA
$10.1B
| $300K | ﹤0.01% |
1,101
-229
| -17% | -$61.1K |
|
1008
Synaptics
SYNA
$4.29B
| $300K | ﹤0.01% |
2,695
-393
| -13% | -$45.3K |
|
1009
Surgery Partners
SGRY
$1.97B
| $297K | ﹤0.01% |
8,617
-574
| -6% | -$18.6K |
|
1010
Meritage Homes
MTH
$4.8B
| $297K | ﹤0.01% |
5,084
+102
| +2% | +$5.49K |
|
1011
Arcturus Therapeutics
ARCT
$224M
| $295K | ﹤0.01% |
12,322
| – | – |
|
1012
Crown Castle
CCI
$32.2B
| $295K | ﹤0.01% |
2,203
-96
| -4% | -$13.3K |
|
1013
Occidental Petroleum
OXY
$57.7B
| $294K | ﹤0.01% |
4,715
-32,267
| -87% | -$2M |
|
1014
Roku
ROKU
$22.8B
| $292K | ﹤0.01% |
+4,438
| New | +$260K |
|
1015
EQT Corp
EQT
$33.6B
| $292K | ﹤0.01% |
9,151
-71,230
| -89% | -$2.28M |
|
1016
Cleveland-Cliffs
CLF
$6.96B
| $291K | ﹤0.01% |
+15,888
| New | +$315K |
|
1017
UMB Financial
UMBF
$11.4B
| $290K | ﹤0.01% |
5,025
-3,861
| -43% | -$314K |
|
1018
Park Hotels & Resorts
PK
$3.02B
| $288K | ﹤0.01% |
23,335
| – | – |
|
1019
M/I Homes
MHO
$3.86B
| $286K | ﹤0.01% |
4,538
-9
| -0.2% | -$518 |
|
1020
ZIM Integrated Shipping Services
ZIM
$3.27B
| $286K | ﹤0.01% |
+12,121
| New | +$255K |
|
|
TBRG
1021
DELISTED
TruBridge
TBRG
| $286K | ﹤0.01% |
9,456
-300
| -3% | -$8.74K |
|
1022
Omnicell
OMCL
$1.7B
| $284K | ﹤0.01% |
4,844
-507
| -9% | -$28K |
|
|
SRC
1023
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $283K | ﹤0.01% |
7,100
| – | – |
|
1024
Construction Partners
ROAD
$6.75B
| $282K | ﹤0.01% |
+10,455
| New | +$285K |
|
|
PLYA
1025
DELISTED
Playa Hotels & Resorts
PLYA
| $281K | ﹤0.01% |
29,276
| – | – |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.